References
- Kannel WB. Blood pressure as a cardiovascular risk factor. JAMA. 1996; 275(24): 1571–1576.
- D'Agostino RB, Belange AJ, Kannel WB. Relation of low blood pressure to coronary heart disease in the presence of myocardial infarction. BMJ. 1991; 303(6799): 385–389.
- Sever PS, Dahlöf B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol contradictions, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003; 361(9364): 1149–1158.
- Staessen JA, Richart T, Verdecchia P, et al. Reducing blood pressure in people of different ages. BMJ. 2008; 336(7653): 1080–1081.
- Chobian AV. The hypertension paradox: more uncontrolled disease despite improved therapy. N Engl J Med. 2009; 361: 878–887.
- Cuspidi C. Cardio-renal organ damage and cardiovascular outcomes in hypertension. J Hypertens. 2009; 27(4): 702–706.
- Williams B, Lindhold LH, Sever P. Systolic pressure is all that matters. Lancet. 2008; 371(9631): 2219–2221.
- Franklin SS, Chow VH, Mori AD, et al. The significance of low DBP in US adults with isolated systolic hypertension. J Hypertens. 2011; 29(6): 1101–1108.
- BPLTTC: Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008; 336(7653): 1121–1123.
- BPLTTC: Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus. Arch Intern Med. 2005; 165(12): 1410–1419.
- Messerli FH, William B, Ritz E. Essential hypertension. Lancet. 2007; 370(9587): 591–603.